156 related articles for article (PubMed ID: 26234938)
1. An MRI Method To Map Tumor Hypoxia Using Red Blood Cells Loaded with a pO2-Responsive Gd-Agent.
Di Gregorio E; Ferrauto G; Gianolio E; Lanzardo S; Carrera C; Fedeli F; Aime S
ACS Nano; 2015 Aug; 9(8):8239-48. PubMed ID: 26234938
[TBL] [Abstract][Full Text] [Related]
2. Generation of multiparametric MRI maps by using Gd-labelled- RBCs reveals phenotypes and stages of murine prostate cancer.
Ferrauto G; Di Gregorio E; Lanzardo S; Ciolli L; Iezzi M; Aime S
Sci Rep; 2018 Jul; 8(1):10567. PubMed ID: 30002426
[TBL] [Abstract][Full Text] [Related]
3. Gd-loaded-RBCs for the assessment of tumor vascular volume by contrast-enhanced-MRI.
Ferrauto G; Di Gregorio E; Dastrù W; Lanzardo S; Aime S
Biomaterials; 2015 Jul; 58():82-92. PubMed ID: 25941785
[TBL] [Abstract][Full Text] [Related]
4. An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography.
Yang CT; Chandrasekharan P; He T; Poh Z; Raju A; Chuang KH; Robins EG
Biomaterials; 2014 Jan; 35(1):327-36. PubMed ID: 24138829
[TBL] [Abstract][Full Text] [Related]
5. Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi's sarcoma.
Grange C; Geninatti-Crich S; Esposito G; Alberti D; Tei L; Bussolati B; Aime S; Camussi G
Cancer Res; 2010 Mar; 70(6):2180-90. PubMed ID: 20215497
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and biodistribution study of self-assembled Gd-micelles demonstrating blood-pool contrast enhancement for MRI.
Vorobiev V; Babič A; Crowe LA; Van De Looij Y; Lenglet S; Thomas A; Helm L; Vallée JP; Allémann E
Int J Pharm; 2019 Sep; 568():118496. PubMed ID: 31279053
[TBL] [Abstract][Full Text] [Related]
7. In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium-based contrast agent.
Chen SH; Kuo YT; Cheng TL; Chen CY; Chiu YY; Lai JJ; Chang CC; Jaw TS; Wang YM; Liu GC
Kaohsiung J Med Sci; 2013 May; 29(5):246-53. PubMed ID: 23639510
[TBL] [Abstract][Full Text] [Related]
8. Differential passage of gadolinium through the mouse inner ear barriers evaluated with 4.7T MRI.
Zou J; Zhang W; Poe D; Zhang Y; Ramadan UA; Pyykkö I
Hear Res; 2010 Jan; 259(1-2):36-43. PubMed ID: 19818391
[TBL] [Abstract][Full Text] [Related]
9. Sensitive MRI detection of internalized T1 contrast agents using magnetization transfer contrast.
Delli Castelli D; Ferrauto G; Di Gregorio E; Terreno E; Aime S
NMR Biomed; 2015 Dec; 28(12):1663-70. PubMed ID: 26474109
[TBL] [Abstract][Full Text] [Related]
10. Sonosensitive theranostic liposomes for preclinical in vivo MRI-guided visualization of doxorubicin release stimulated by pulsed low intensity non-focused ultrasound.
Rizzitelli S; Giustetto P; Cutrin JC; Delli Castelli D; Boffa C; Ruzza M; Menchise V; Molinari F; Aime S; Terreno E
J Control Release; 2015 Mar; 202():21-30. PubMed ID: 25626083
[TBL] [Abstract][Full Text] [Related]
11. Contrast enhanced lung MRI in mice using ultra-short echo time radial imaging and intratracheally administrated Gd-DOTA-based nanoparticles.
Bianchi A; Lux F; Tillement O; Crémillieux Y
Magn Reson Med; 2013 Nov; 70(5):1419-26. PubMed ID: 23233439
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study.
de Smet M; Heijman E; Langereis S; Hijnen NM; Grüll H
J Control Release; 2011 Feb; 150(1):102-10. PubMed ID: 21059375
[TBL] [Abstract][Full Text] [Related]
13. Quantitative dynamic contrast-enhanced MRI in tumor-bearing rats and mice with inversion recovery TrueFISP and two contrast agents at 4.7 T.
Weidensteiner C; Rausch M; McSheehy PM; Allegrini PR
J Magn Reson Imaging; 2006 Sep; 24(3):646-56. PubMed ID: 16878308
[TBL] [Abstract][Full Text] [Related]
14. Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4.
Fruytier AC; Magat J; Neveu MA; Karroum O; Bouzin C; Feron O; Jordan B; Cron GO; Gallez B
NMR Biomed; 2014 Nov; 27(11):1403-12. PubMed ID: 25323069
[TBL] [Abstract][Full Text] [Related]
15. Ultra-high field 1H magnetic resonance imaging approaches for acute hypoxia.
Nielsen T; Nielsen NC; Holm TH; Ostergaard L; Horsman MR; Busk M
Acta Oncol; 2013 Oct; 52(7):1287-92. PubMed ID: 23992112
[TBL] [Abstract][Full Text] [Related]
16. Gd-DOTA loaded into red blood cells, a new magnetic resonance imaging contrast agents for vascular system.
Kravtzoff R; Urvoase E; Chambon C; Ropars C
Adv Exp Med Biol; 1992; 326():347-54. PubMed ID: 1295322
[No Abstract] [Full Text] [Related]
17. Blood oxygenation level dependent, blood volume, and blood flow responses to carbogen and hypoxic hypoxia in 9L rat gliomas as measured by MRI.
Jerome NP; Hekmatyar SK; Kauppinen RA
J Magn Reson Imaging; 2014 Jan; 39(1):110-9. PubMed ID: 23553891
[TBL] [Abstract][Full Text] [Related]
18. In vivo MRI multicontrast kinetic analysis of the uptake and intracellular trafficking of paramagnetically labeled liposomes.
Delli Castelli D; Dastrù W; Terreno E; Cittadino E; Mainini F; Torres E; Spadaro M; Aime S
J Control Release; 2010 Jun; 144(3):271-9. PubMed ID: 20230865
[TBL] [Abstract][Full Text] [Related]
19. Gadolinium chelate with DO3A conjugated 2-(diphenylphosphoryl)-ethyldiphenylphosphonium cation as potential tumor-selective MRI contrast agent.
Chandrasekharan P; Yong CX; Poh Z; He T; He Z; Liu S; Robins EG; Chuang KH; Yang CT
Biomaterials; 2012 Dec; 33(36):9225-31. PubMed ID: 23026708
[TBL] [Abstract][Full Text] [Related]
20. Improved tumor-targeting MRI contrast agents: Gd(DOTA) conjugates of a cycloalkane-based RGD peptide.
Park JA; Lee YJ; Ko IO; Kim TJ; Chang Y; Lim SM; Kim KM; Kim JY
Biochem Biophys Res Commun; 2014 Dec; 455(3-4):246-50. PubMed ID: 25449282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
